Panitumumab, a fully human Anti-EGFR monoclonal antibody, augments radiation response in xenograft models of upper aerodigestive tract cancers

被引：3
|
作者：
Kruser, T. J. [1 ]
Armstrong, E. [1 ]
Huang, S. [1 ]
Radinsky, R. [2 ]
Stames, C. [2 ]
Freeman, D. [2 ]
Harari, P. M. [1 ]
机构：
[1] Univ Wisconsin, Sch Publ Hlth & Med, Dept Human Oncol, Madison, WI USA
[2] Amgen Inc, Dept Oncol Res, Thousand Oaks, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2007.07.1934
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2751
引用
收藏
页码：S615 / S616
页数：2
相关论文
共 50 条
  • [1] Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer
    Kruser, Tim J.
    Armstrong, Eric A.
    Ghia, Amol J.
    Huang, Shyhmin
    Wheeler, Deric L.
    Radinsky, Robert
    Freeman, Daniel J.
    Harari, Paul M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (02): : 534 - 542
  • [2] Panitumumab.: Oncolytic -: Anti-EGFR human monoclonal antibody.
    McIntyre, JA
    Martín, L
    DRUGS OF THE FUTURE, 2004, 29 (08) : 793 - 797
  • [3] Review article: panitumumab - a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer
    Peeters, M.
    Balfour, J.
    Arnold, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (03) : 269 - 281
  • [4] Infusion reactions to the chimeric EGFR inhibitor cetuximab-change to the fully human anti-EGFR monoclonal antibody panitumumab is safe
    Resch, G.
    Schaberl-Moser, R.
    Kier, P.
    Kopetzky, G.
    Scheithauer, W.
    Sliwa, T.
    Greil, R.
    Noesslinger, T.
    Mayrbaeurl, B.
    Thaler, J.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 486 - U251
  • [5] Sym004, a Novel Anti-EGFR Antibody Mixture, Augments Radiation Response in Human Lung and Head and Neck Cancers
    Huang, Shyhmin
    Peet, Chimera R.
    Saker, Jarob
    Li, Chunrong
    Armstrong, Eric A.
    Kragh, Michael
    Pedersen, Mikkel W.
    Harari, Paul M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (12) : 2772 - 2781
  • [6] Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab
    You, Benoit
    Chen, Eric X.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (02): : 128 - 155
  • [7] Sym004, a novel anti-EGFR antibody mixture augments radiation response in human lung and head and neck cancer models
    Huang, Shyhmin
    Armstrong, Eric A.
    Kragh, Michael
    Pedersen, Mikkel W.
    Harari, Paul M.
    CANCER RESEARCH, 2012, 72
  • [8] In vivo molecular imaging with cetuximab, an anti-EGFR antibody, for prediction of response in xenograft models of human colorectal cancer
    Goetz, M.
    Hoetker, M. S.
    Diken, M.
    Galle, P. R.
    Kiesslich, R.
    ENDOSCOPY, 2013, 45 (06) : 469 - 477
  • [9] Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
    Milenic, Diane E.
    Baidoo, Kwamena E.
    Kim, Young-Seung
    Barkley, Rachel
    Brechbiel, Martin W.
    TRANSLATIONAL ONCOLOGY, 2017, 10 (04): : 535 - 545
  • [10] RAS mutations as markers of resistance for colorectal cancer patients treated with the anti-EGFR monoclonal antibody panitumumab
    Oliner, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S7 - S8
12345